Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

Cited by (104)

Items 101–104 of 104

1. Amyloidogenic amylin signaling links diabetes to dementia pathogenesis
   Florin Despa, Tammaryn Lashley · 2026 · Trends in Pharmacological Sciences
2. Beyond GLP-1: Amylin-based pharmacotherapy and the search for better-tolerated weight-loss drugs
   Sophia L. Fischer, Tito Borner · 2026 · Pharmacological Research
3. Serum amylin levels in patients with multiple sclerosis
   Ufuk ÇINKIR, Levent Sinan Bir, Selma Tekin, Ahmet Mağrur Karagülmez, Esin Avcı, Hande Şenol · 2026 · Medicine
4. Petrelintide and the evolving role of amylin agonism in obesity
   Sten Madsbad, Jens Juul Holst · 2026 · The Lancet Diabetes & Endocrinology